Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases

Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases

US Patent 7943768 · Granted May 17, 2011

Estimated economic value: $6,691,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic nitrogen containing heterocycles as inhibitors of salt-induced kinase S2025
Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer2022
Heterocyclic compounds as CCR2B antagonists2014
Heterocyclic compounds as CCR2B antagonists2014
Pyridine and pyrazine derivatives -0832011
Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-22011
Heterocyclic compounds as ccr2b antagonists2011
Heterocyclic compounds as ccr2b antagonists2011
Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme IKK-2009
Thiophene carboxamides as inhibitors of the enzyme IKK-22009
Method of producing an antiangiogenic or vascular permeability reducing effect2009
Guanidine derivatives quinazoline and quinoline for use in the treatment of auto2006